Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1312studies shown
Showing 13-24 of 1,312
Device study icon
RecruitingNCT04557891

Low-Intensity Focused Ultrasound Pulsation (LIFUP) for Generalized Anxiety Disorder (GAD)

This study is comparing Active LIFUP Treatment with Sham for people with Generalized anxiety. Participants receive Active LIFUP Treatment or Sham and complete study visits and assessments.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Anxiety.

AnxietyDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Anxiety
Behavioral study icon
RecruitingNCT06846320

Adverse Events and Change for anxiety

This study is recruiting in the United States. It is testing adverse Events and Change for anxiety.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Anxiety.

AnxietyBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Anxiety
Behavioral study icon
RecruitingNCT06937892

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders

This study is looking at how a digital support tool works for people with Generalized anxiety, Social anxiety, or PTSD in routine care. Participants take part in a digital support tool and complete follow-up assessments.

In Stockholm
Why is this study shown?

This study is directly about Anxiety.

Anxiety, PTSDBehavioralOver 18 Years
Countries
Sweden
Sponsor
Karolinska Institutet
Condition
Anxiety, PTSD
Drug study icon
RecruitingNCT07478744

Safety study of SYT-510 in anxiety

This study is recruiting in the United Kingdom. It is testing SYT-510 for anxiety.

In London
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Synendos Therapeutics AG
Condition
Anxiety
Drug study icon
RecruitingNCT07489651

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

This study is comparing RE104 for Injection with placebo for people with Generalized anxiety. Participants receive RE104 for Injection or placebo and complete study visits and assessments.

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugFrom 18 Years to 74 Years
Countries
United States
Sponsor
Reunion Neuroscience Inc
Condition
Anxiety
Drug study icon
RecruitingNCT07323784

NTX-1472 in Social Anxiety Disorder

This study is recruiting in the United States. It is testing NTX-1472 for anxiety.

Multiple locations, including Encino
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.